Zhejiang Davi Pharmaceutical Co.
浙江大美製薬株式会社
2004 年に設立された Zhejiang Davi Pharmaceutical Co., Ltd. は、医薬品原薬および中間体を製造する外資独占のハイテク メーカーです。総投資額は800万米ドル、占有床面積は35,000平方メートルの同社は、上海、杭州、江蘇に囲まれた湖州市に位置し、優れた立地と交通の便に優れています。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Area Huzhou city, China
- Website
- https://www.davipharm.com
- Categories
- 医薬品製造, 化学薬品とプラスチック, サプリメントとウェルネス
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- domain-registered (green), checked 2026-08-08 Domain registry record
- sanctions-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)